Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MannKind Catalysts: Insights About Diabetes Care Metrics And Long-Term Complications
Seeking Alpha
Thursday, January 23, 2014 - 8:19am
tags:
diabetes, MannKind, Afrezza
3 Lessons From the Biggest Biotech Event of 2014
Motley Fool
Thursday, January 23, 2014 - 8:18am
tags:
biotech, JPMHC 2014, Sangamo BioSciences, Biogen Idec, Amag Pharmaceuticals, Portola Pharmaceuticals
Baxter Predicts 2014 Earnings That Surpass Estimates on Dialysis
Bloomberg
Thursday, January 23, 2014 - 7:52am
tags:
Baxter International, earnings, devices
BioLine Rx Ltd receives orphan drug designation for novel stem cell mobilization treatment
Reuters
Thursday, January 23, 2014 - 7:51am
tags:
stem cells, BioLineRx, BL-8040, AML, acute myeloid leukemia
Teva appeals to Supreme Court for help thwarting Copaxone rivals
Fierce Pharma
Thursday, January 23, 2014 - 7:50am
tags:
Copaxone, Teva Pharmaceuticals, patents, MS, Supreme Court, multiple sclerosis
Amarin Tumbles after DMEP Decision
Yahoo/Zacks.com
Wednesday, January 22, 2014 - 5:23pm
tags:
Amarin, DMEP, Vascepa
Regulators Ask: Is FDA's Generic Drug Submission Process Broken?
Regulatory Focus
Wednesday, January 22, 2014 - 5:22pm
tags:
FDA, generics
Stryker fourth quarter net profit rises 43 percent
Reuters
Wednesday, January 22, 2014 - 5:20pm
tags:
Stryker, devices, earnings
Narrower-than-Expected Loss at Ironwood, Shares Up
Yahoo/Zacks.com
Wednesday, January 22, 2014 - 5:19pm
tags:
earnings, Ironwood Pharmaceuticals
Athersys-Pfizer Investors: Anticipating A Phase III Trial For Inflammatory Bowel Disease
Seeking Alpha
Wednesday, January 22, 2014 - 5:16pm
tags:
Athersys, inflammatory bowel disease, MAPCs, Pfizer
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal
Yahoo/Zacks.com
Wednesday, January 22, 2014 - 4:14pm
tags:
Sarepta Therapeutics, Alnylam, Jazz Pharmaceuticals, Regeneron, Celgene
Why Investors Are Shrugging Off Amag Pharma's Feraheme FDA Rejection
TheStreet.com
Wednesday, January 22, 2014 - 3:50pm
tags:
Amag Pharmaceuticals, FDA, Feraheme
Nektar Momentum Continues To Grow
Seeking Alpha
Wednesday, January 22, 2014 - 3:46pm
tags:
Nektar, Naloxegol
Quest will buy Solstas Lab Partners for $570M
Yahoo/AP
Wednesday, January 22, 2014 - 11:10am
tags:
Quest Diagnostics, M&A, Solstas Lab Partners
NuVasive loses a bid to toss a patent infringement lawsuit filed by AngleFix over plate-and-screw spinal implant technology
Mass Device
Wednesday, January 22, 2014 - 10:48am
tags:
NuVasive, AngleFix, devices
EMA Bests FDA in 2013 New Drug Approval Numbers
Fierce Biotech
Wednesday, January 22, 2014 - 10:40am
tags:
EMA, FDA, drug approvals
Novartis to Shut New York Plant as Diovan Sales Decline
Bloomberg
Wednesday, January 22, 2014 - 10:24am
tags:
Novartis, drug manufacturing, Diovan
Q4 venture haul pushes 2013 biotech investing past $4.5B
Fierce Biotech
Wednesday, January 22, 2014 - 10:21am
tags:
biotech
What's a $2.9B deal + increasing sales equal? One enthused new CEO at Forest
Fierce Pharma
Wednesday, January 22, 2014 - 10:19am
tags:
Forest Labs, Pharma CEOs, Brent Saunders
Teva Acquisition Machine Gears Up: Who Is the Next Target?
Yahoo/24-7 Wall St
Wednesday, January 22, 2014 - 8:41am
tags:
Teva Pharmaceuticals, M&A, Idenix, Insmed, NuPathe, InterMune, Puma Biotechnology

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.